data 42.38 | MDT Message Board Posts

Medtronic Inc.

  MDT website

  • Please accept my sincerest apologies for failing to publicly acknowledge our fallen heroes this past Memorial Day. No excuse I could offer could justify the oversight. Along with you, I salute the many men and women who have proudly and selflessly served in our military to protect, defend and secure the freedoms and liberties we enjoy each and every day. Their bravery in making the ultimate sacrifice will forever be appreciated and they will always be remembered and celebrated and never taken for granted or forgotten.

MDT   /  Message Board  /  Read Message



Rec'd By
Authored By
Minimum Recs
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  43 of 45  at  10/22/2012 10:59:48 AM  by


data 42.38

Medtronic announces data from CoreValve ADVANCE Study & Symplicity HTN-1 (MDT) 42.00 : Co announced new findings from the Medtronic CoreValve ADVANCE Study for 1-year survival and health-related quality of life (HRQoL). The findings were presented this week at Transcatheter Cardiovascular Therapeutics (TCT) Meeting 2012 in Miami. Initial 1-year results of the ADVANCE Study revealed that patients experienced high survival rates, with 1-year survival at 82.1 percent and 1-year cardiovascular survival at 88.2 percent. Health-related quality of life (HRQoL) measures for patients in the ADVANCE Study improved significantly at 1 and 6 months, compared with their status prior to receiving the Medtronic CoreValve System.

Co also announced new results from Symplicity HTN-1, the longest running clinical trial investigating the safety and efficacy of renal denervation. These data showed patients who received renal denervation treatment with the Symplicity system experienced a mean blood pressure reduction of -29/-14 mm Hg [p<0.01] at 24 months (n=105). These data expand the total number of patients to nearly two times the number previously reported at 24 months (n=59) from this clinical trial. The safety of renal denervation with the Symplicity system was also maintained at 24 months.

     e-mail to a friend      printer-friendly     add to library      
Recs: 0  
   Views: 333 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Financial Market Data provided by